MOTS-c and SS-31 are both discussed in mitochondrial research, which is why they are often compared – but they are not variations on the same idea. One is a peptide the mitochondrion itself encodes and releases as a signal. The other is a synthetic sequence designed to concentrate at a specific lipid in the inner mitochondrial membrane.
- MOTS-c
- Mitochondrial-derived signalling peptide
- SS-31
- Cardiolipin-targeting tetrapeptide
- MOTS-c origin
- Encoded in mitochondrial DNA
- SS-31 origin
- Synthetic, designed sequence
The short answer
MOTS-c is a mitochondrial-derived peptide: it is encoded within mitochondrial DNA and studied as a signalling molecule that communicates from the mitochondrion to the cell nucleus. SS-31 is a synthetic tetrapeptide studied for its affinity to cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane. MOTS-c is studied as a signal; SS-31 is studied as a structural interaction at the membrane.
| MOTS-c | SS-31 | |
|---|---|---|
| Origin | Encoded in mitochondrial DNA | Synthetic designed sequence |
| Length | 16 amino acids | 4 amino acids |
| Primary research interest | Mitochondria-to-nucleus signalling | Cardiolipin / inner membrane |
| Typical study model | Cell and rodent metabolic models | Cell and rodent models |
| Evidence stage | Mechanistic, preclinical | Mechanistic, preclinical |
MOTS-c: a signal from the mitochondrion
MOTS-c is unusual because it is encoded inside mitochondrial DNA rather than in the cell nucleus. Published mechanistic work describes it as a retrograde signal – information travelling from mitochondrion outward – with observed effects on metabolic signalling pathways in cell and rodent models. Research interest centres on that signalling role and on how its expression changes under metabolic stress.
SS-31: a membrane-targeting design
SS-31 is a synthetic tetrapeptide whose research interest comes from where it accumulates. Published work describes an affinity for cardiolipin, a phospholipid found in the inner mitochondrial membrane, and studies its interaction with that membrane in models of mitochondrial dysfunction. The mechanism under investigation is structural and local rather than signalling and systemic.
What the evidence does and does not show
Both compounds sit at a similar evidence stage: mechanistic and largely preclinical, with cell-model and rodent work forming the bulk of the literature. Neither has the kind of large, long-duration human trial record that exists for older compound classes. Research designs treating either as an established intervention are not supported by the published literature.
Because the two engage mitochondrial biology at different levels – signalling versus membrane interaction – published work does not position them as substitutes for one another.
All compounds referenced here are supplied as analytical-grade reference materials for in-vitro and laboratory research only. Nothing on this page is a recommendation for human or veterinary use, and no comparison below should be read as ranking these materials for any personal outcome.
Studies cited
- MOTS-c and metabolic disorders (Metabolites, 2023)
- MOTS-c and muscle-atrophy signaling (American journal of physiology. Endocrinology and metabolism, 2021)
- MOTS-c mitochondrial peptide — therapeutic overview (Frontiers in endocrinology, 2023)
- Elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide transporter (GeroScience, 2023)
- The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics (The Journal of biological chemistry, 2020)
- Elamipretide: a review of its structure, mechanism of action, and therapeutic potential (International journal of molecular sciences, 2025)
Questions
What is the main difference between MOTS-c and SS-31?
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA and studied as a signalling molecule between the mitochondrion and the nucleus. SS-31 is a synthetic 4-amino-acid peptide studied for its affinity to cardiolipin in the inner mitochondrial membrane. One is studied as a signal, the other as a membrane interaction.
Is MOTS-c a natural peptide?
MOTS-c is encoded within mitochondrial DNA rather than nuclear DNA, which makes it a mitochondrial-derived peptide. The material supplied for research is synthesized to match that sequence.
Are MOTS-c and SS-31 studied for the same thing?
Both appear in mitochondrial research, but they engage mitochondrial biology at different levels and the published literature does not present them as interchangeable. MOTS-c work centres on signalling pathways; SS-31 work centres on the inner mitochondrial membrane.
How strong is the evidence for either?
The evidence for both MOTS-c and SS-31 is mechanistic and largely preclinical, based on cell-model and rodent studies. Neither has a large, long-duration published human trial record.
For laboratory research and educational purposes only. Not medical advice. The materials discussed are not for human or animal consumption and have not been evaluated by the FDA.